Exhibit 107
Calculation of Filing Fee Tables
Form S-3
(Form Type)
Whitehawk Therapeutics, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
| Security Type |
Security Class |
Fee Calculation Rule |
Amount Registered(1)(2) |
Proposed Maximum Offering Price Per Unit(3) |
Maximum Aggregate Offering Price(3) |
Fee Rate |
Amount of Registration Fee | |||||||||
| Fees to be Paid | Equity | Common Stock, $0.0001 par value per share | 457(c) | 41,668,500 | $1.90 | $79,170,150.00 | 0.00015310 | $12,120.95 | ||||||||
| Total Offering Amounts | $79,170,150.00 | $12,120.95 | ||||||||||||||
| Total Fees Previously Paid | $0 | |||||||||||||||
| Net Fee Due | $12,120.95 | |||||||||||||||
| (1) | Pursuant to Rule 416(a) of the Securities Act of 1933, as amended, this registration statement shall also cover any additional shares of the registrant’s common stock that become issuable by reason of any stock dividend, stock split, recapitalization or other similar transaction effected without receipt of consideration that increases the number of the registrant’s outstanding shares of common stock. |
| (2) | This registration statement registers 21,592,000 outstanding shares of common stock of the registrant and 20,076,500 shares of common stock of the registrant issuable upon the exercise of pre-funded warrants issued by the registrant at an exercise price of $0.0001 per share. |
| (3) | Estimated solely for the purpose of calculating the registration fee according to Rule 457(c) under the Securities Act of 1933, as amended, based on the average of the high ($1.93) and low ($1.87) prices of the registrant’s common stock reported on the Nasdaq Capital Market on March 27, 2025, which is within five business days prior to filing this registration statement. |